Month: February 2021

Uponor Oyj     Pörssitiedote     11.2.2021     8.10Suunnattu anti yhtiön johdolle osana vuosien 2018–2020 osakekannustinohjelmaaUponor Oyj:n hallitus päätti yhtiökokouksen 16.3.2020 antamaan valtuutukseen perustuen toteuttaa suunnatun annin yhtiön johdolle osana yhtiön osakesidonnaista kannustinohjelmaa vuosille 2018–2020. Hallituksen päätöksellä luovutetaan korvauksetta yhteensä 45 659 yhtiön hallussa olevaa osaketta 33 avainhenkilölle kannustinohjelman ehtojen mukaisesti.Osakekannustimet ovat osa Uponorin johdon kokonaispalkkausta. Niiden tarkoituksena on kannustaa ja motivoida johtajia ja yhdenmukaistaa johdon ja osakkeenomistajien tavoitteita.Vuosien 2018–2020 kannustinohjelman palkkio koostui yhtiön tuloskehityksestä riippuvasta suoriteperusteisesta osakekannustinohjelmasta kolmen vuoden ansaintajaksolla.Yksityiskohtaisempia tietoja...

Financial highlights 2020GN delivered DKK 13.4 billion revenue with organic revenue growth of 9%EBITA of DKK 1.9 billion and EPS was DKK 9.72Free cash flow excl. M&A was DKK 1.9 billion and net interest-bearing debt was 1.8x EBITDAGN Store Nord managed the unprecedented challenges well in 2020. In a year when the entire world was heavily burdened by the global pandemic, GN adjusted appropriately, never compromising on innovation, launching multiple well-received state-of-the-art products, and managing expenditure diligently.In 2020, GN Store Nord was affected in three ways by COVID-19: (i) Various impact on production capacity and supply of components from subcontractors in H1 2020, (ii) GN Audio experienced strong demand as enterprises invested in employees working from home, and (iii) GN Hearing was impacted by lockdowns and local...

MINNEAPOLIS, Feb. 10, 2021 (GLOBE NEWSWIRE) — Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced that it has entered into definitive agreements with several institutional and accredited investors for the issuance and sale of an aggregate of approximately 4,222,288 shares of its common stock, at a purchase price of $1.75 per share, for gross proceeds of approximately $7.4 million in a registered direct offering priced at-the-market under Nasdaq rules. Predictive Oncology has also agreed to issue to the investors unregistered warrants to purchase up to an aggregate of approximately 2,111,114 shares of common stock. The closing of the offering is expected to occur...

VANCOUVER, British Columbia, Feb. 11, 2021 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE: PVG) (“Pretivm” or the “Company”) today announces that a Covid-19 outbreak has been verbally declared at the Brucejack Mine by the BC Northern Health Medical Health Officer. To protect the health and safety of our workforce and local communities, the Company has implemented enhanced outbreak protocols which include restrictions on travel to and from the Brucejack Mine Camp until site wide testing and an assessment by BC Northern Health can be completed.   Currently, the Company is managing 14 cases of COVID-19 among employees and contractors at the Brucejack Mine, this includes those previously announced 9 cases (see news release dated February 7, 2021). All are in isolation, remain in good health and have exhibited limited symptoms....